Clinical Trials Results - National Cancer Institute


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -10 of 17 Show results per page	View Search Criteria \| Help With Results

Last Modified: 4/26/2007


1.		Phase III Randomized Study of Autolymphocyte Therapy Using AL101 plus Cimetidine vs Cimetidine Alone in Patients with Renal Cell Carcinoma (Summary Last Modified 08/89)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 18								BUMC-MS-1 NCI-V88-0412

Last Modified: 12/1/1993


2.		Phase III Study of Adjuvant Autolymphocyte Therapy for T1-3 N1-3 M0 or T4 N0-3 M0 Renal Cell Carcinoma (Summary Last Modified 12/93)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				over 18								CUCCC-90-C01 NCI-V91-0009

Last Modified: 3/1/1994


3.		Phase III Randomized Double-Blind Placebo-Controlled Trial of Cimetidine in Patients with Gastric Cancer (Summary Last Modified 03/94)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Treatment				Closed				any age								CRC-TU-GA3004 EU-90033

Last Modified: 6/7/2004


4.		Phase II Study of Autologous Activated Lymphocytes plus Immunomodulation with High-Dose Cimetidine in Patients with Metastatic Cancer (Summary Last Modified 12/98)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over				Other				CBRG-9115 NBSG-9115, NCI-V93-0342

Last Modified: 3/19/2007


5.		Phase II Study of Interferon alfa and Interleukin-2 in Patients With Metastatic Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 to physiologic 75				Other				CBRG-9510 NBSG-9510, NCI-V96-0835, NCT00002733

Last Modified: 12/6/2007


6.		Phase II Therapy with PALA/L-Alanosine and with Cimetidine as a Single Agent for Metastatic Malignant Melanoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				no age specified				NCI				NCCTG-837051 NCCTG-83-70-51


7.		Phase II Immunotherapy with Subcutaneous Alpha-2-Interferon in Patients with Multiple Myeloma, plus Cimetidine for Treatment Failures

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				18 and over								YALE-HIC-3027 NCI-V84-0057

Last Modified: 10/1/1988


8.		Phase II Study of Autolymphocyte Therapy for the Treatment of Cancer for Which There is No Conventional Therapy Available (Summary Last Modified 10/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								BUMC-CT-2 NCI-V88-0411


9.		Phase II Autolymphocyte Therapy in Patients with Cancer for Which No Other Therapy Exists

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Closed				over 18								BUMC-8603 NCI-V86-0041

Last Modified: 9/1/1988


10.		Phase II Randomized Study of Chemoimmunotherapy with IFL-RA/BCNU and BCNU/Cimetidine in Patients with Advanced Malignant Melanoma (Summary Last Modified 09/88)

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II				Treatment				Completed				18 and over				NCI				NCCTG-857051 MAYO-857051, NCCTG-85-70-51

Select All on One Page


					1 2 Next >

| | | | | | | |

A Service of the National Cancer Institute